Substituted tricyclic compounds as inhibitors of Fibroblast Growth Factor receptor (FGFR). (Divisional Application 3355 - 2014)

摘要

p The present Invention relates to compounds of the formula I and tricyclic, Pharmaceutical compositions of the sameThey are inhibitors of one or more Enzymes of FGFR and are useful in the treatment of diseases such as cancer associated with FGFR,In which the Radicals are as described in the claims. / p